Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?
Abstract Inflammatory response, oxidative stress, and endoplasmic reticulum (ER) stress are important pathophysiological bases of the occurrence and development of diabetes mellitus (DM) and macroangiopathy complications. Selenoprotein S (SELENOS) is involved in the regulation of these mechanisms; t...
Main Authors: | Shan-shan Yu, Jian-ling Du |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-017-0585-8 |
Similar Items
-
Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers
by: Shan-shan Yu, et al.
Published: (2024-01-01) -
Diabetic macroangiopathy
by: A F Verbovoy, et al.
Published: (2019-10-01) -
A case–control study of selenoprotein genes polymorphisms and autoimmune thyroid diseases in a Chinese population
by: Ling Xiao, et al.
Published: (2017-05-01) -
The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01) -
Modern concept of biological identification of selenoproteins
by: N. V. Stanishevska
Published: (2018-10-01)